Diebold Nixdorf, Incorporated ( DBD) - Key Metrics
DBD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $30.42 | $1.37 | $5.99 | $5.58 |
| 2025Q3 | $25.48 | $1.11 | $1.01 | $0.66 |
| 2025Q2 | $24.60 | $0.33 | $0.81 | $0.34 |
| 2025Q1 | $22.37 | -$0.22 | $0.42 | $0.16 |
DBD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 12.42 |
| 2025Q3 | ? | 12.87 |
| 2025Q2 | 16.39% | 42.23 |
| 2025Q1 | ? | -49.51 |
DBD Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.99% | ? |
| 2025Q4 | 8.34% | ? |
| 2025Q3 | 1.16% | ? |
| 2025Q2 | 0.62% | 0.10% |
| 2025Q1 | 0.37% | ? |
DBD
Price: $81.64
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.90 USD
P/E Ratio: 28.05
Exchange: NYQ
Sector: Technology
Industry: Software - Application
Volume: 1.9 million
Ebitda: 81.7 millionMarket Capitalization: 2.8 billion